文献速递放疗物理与技术

植入式电子设备(非心脏起搏器或除颤器)患者管理的放射肿瘤学政策示例

Example Radiation Oncology Policy for Managing Patients With Implanted Electronic Devices Other Than Implantable Cardiac Pacemakers or Defibrillators.
PubMed 文献 · Pract Radiat Oncol · 2023-08-14

本文描述了一家社区医院针对携带非心脏起搏器或植入式心脏除颤器(ICD)的医疗植入式电子设备患者的管理政策。该政策采用基于风险的方法,根据患者对设备的依赖程度、设备预期剂量和治疗类型确定风险等级,并于2022年被采纳为科室政策,目前在该社区医院运行。

要点

  • 政策采用基于风险的方法,依据设备依赖程度、预期剂量和治疗类型确定风险等级。
  • 涵盖设备包括肝泵、鞘内疼痛泵、神经刺激器、人工耳蜗和循环记录器等。
  • 政策包含患者监测级别和设备询问时机建议,以尽量减少设备故障风险。

核心结论

  • 该政策旨在指导携带一系列医疗植入式电子设备患者的治疗管理,目前在一家社区医院运行。

研究设计与样本

  • 本文描述了一家社区医院针对携带非心脏起搏器或植入式心脏除颤器(ICD)的医疗植入式电子设备患者的管理政策。
  • 政策采用基于风险的方法制定,每个患者的风险等级基于其对设备的依赖程度、设备预期剂量和治疗类型确定。

主要发现

  • 政策涵盖的设备包括但不限于肝泵、鞘内疼痛泵、神经刺激器、人工耳蜗和循环记录器。
  • 政策中的建议包括患者监测级别和设备询问时机,以尽量减少设备故障风险。

关键数值与推荐

  • 风险等级基于患者对设备的依赖程度、设备预期剂量和治疗类型确定。
  • 政策包含患者监测级别和设备询问时机的建议。

临床怎么用

  • 该政策于2022年在机构的多学科放射肿瘤学质量保证委员会月度会议上提出并被采纳为科室政策。
  • 该政策目前在一家社区医院运行,可据需调整以适应其他需要实用解决方案的放射肿瘤学团队。
  • 对于提供质子、中子、重离子或磁共振引导直线加速器(MR-linac)治疗模式的科室,需对政策进行修改。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This article describes a community-based hospital's policy for the management of patients with medical implanted electronic devices other than pacemakers or implanted cardiac defibrillators (ICDs). The policy may be adapted as needed for other radiation oncology groups requiring a practical solution for managing the care of patients with implanted devices, noting the need for changes for departments offering proton, neutron, heavy ion, or magnetic resonance-guided linear accelerator (MR-linac) treatment modalities. METHODS AND MATERIALS: The policy was developed using a risk-based approach, with each patient's risk level determined based on the patient's dependence on the device, the anticipated dose to the device, and the type of treatment used. A similar approach is used for patients with pacemakers or ICDs, but this policy was designed to accommodate patients with other types of devices with care managed outside the department. Such devices include, but are not limited to, hepatic pumps, intrathecal pain pumps, neurostimulators, cochlear implants, and loop recorders. RESULTS: The resulting definitions, guidelines, and proposed workflow were presented at the institution's multidisciplinary radiation oncology quality assurance committee monthly meeting and adopted as department policy in 2022. Recommendations incorporated in the policy include levels of patient monitoring and timing of device interrogation to minimize the risk of device malfunction. CONCLUSIONS: The policy was written to guide the management of treatment of patients with a range of medical implanted electronic devices. This policy is currently in operation at a community-based hospital.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Fagerstrom JM, Marotta JE. Example Radiation Oncology Policy for Managing Patients With Implanted Electronic Devices Other Than Implantable Cardiac Pacemakers or Defibrillators. Pract Radiat Oncol. 2023. PMID: 37578411. doi:10.1016/j.prro.2023.07.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。